デフォルト表紙
市場調査レポート
商品コード
1746982

日本の自動注射器市場レポート:タイプ、用途、エンドユーザー、地域別、2025~2033年

Japan Autoinjector Market Report by Type (Disposable Autoinjectors, Reusable Autoinjectors), Application (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, and Others), End User (Home Care Settings, Hospitals and Clinics), and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 116 Pages
納期
5~7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
日本の自動注射器市場レポート:タイプ、用途、エンドユーザー、地域別、2025~2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 116 Pages
納期: 5~7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の自動注射器市場規模は2024年に9,360万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに3億9,350万米ドルに達し、2025~2033年の間に16.3%の成長率(CAGR)を示すと予測しています。ヘルスケア産業における数多くの進歩、政府機関による規制承認、ユーザーフレンドリーなドラッグデリバリーシステムを使用することの人気の高まりは、国全体の市場成長を促進する主要因のいくつかを表しています。

本レポートで扱う主要質問

  • 日本の自動注射器市場はこれまでどのように推移し、今後どのように推移するのか?
  • COVID-19が日本の自動注射器市場に与えた影響は?
  • 日本の自動注射器市場のタイプ別区分は?
  • 日本の自動注射器市場の用途別区分は?
  • 日本の自動注射器市場のエンドユーザー別区分は?
  • 日本の自動注射器市場のバリューチェーンにおける様々なステージとは?
  • 日本の自動注射器の主要な促進要因と課題は何か?
  • 日本の自動注射器市場の構造と主要参入企業は?
  • 日本の自動注射器市場における競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本の自動注射器市場-イントロダクション

  • 概要
  • 市場力学
  • 産業動向
  • 競合情報

第5章 日本の自動注射器市場情勢

  • 過去と現在の市場動向(2019~2024年)
  • 市場予測(2025~2033年)

第6章 日本の自動注射器市場-タイプ別内訳

  • 使い捨て自動注射器
  • 再利用型自動注射器

第7章 日本の自動注射器市場-用途別内訳

  • 関節リウマチ
  • アナフィラキシー
  • 多発性硬化症
  • その他

第8章 日本の自動注射器市場-エンドユーザー別内訳

  • 在宅ケア
  • 病院とクリニック

第9章 日本の自動注射器市場-競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第10章 主要企業のプロファイル

第11章 日本の自動注射器市場-産業分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第12章 付録

目次
Product Code: SR112025A18969

Japan autoinjector market size reached USD 93.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 393.5 Million by 2033, exhibiting a growth rate (CAGR) of 16.3% during 2025-2033. Numerous advancements in the healthcare industry, regulatory approvals by government bodies, and the inflating popularity of using user-friendly drug delivery systems represent some of the key factors driving the market growth across the country.

Autoinjector are devices designed for self-administration of drugs through subcutaneous or intramuscular routes. They provide numerous benefits, including precise dosage delivery, enhanced patient adherence, and the mitigation of needle-related anxieties. These devices effectively address needle phobia, reduce the risk of needlestick injuries due to concealed needles, and streamline the healthcare process for professionals. Autoinjectors play a crucial role in emergency situations like anaphylaxis, migraines, status epilepticus, psoriasis, diabetes, multiple sclerosis, and rheumatoid arthritis. Consequently, their widespread use is observed in various healthcare settings, encompassing hospitals, clinics, and home care centers throughout Japan. The versatility and efficiency of autoinjectors contribute significantly to improving medical outcomes while providing a more accessible and user-friendly approach to drug administration in diverse medical conditions.

Japan Autoinjector Market Trends:

The Japan autoinjector market is propelled by a convergence of numerous healthcare advancements and local trends. Additionally, the aging population and increasing prevalence of chronic diseases in the country drive the demand for user-friendly drug delivery systems like autoinjectors, which is acting as significant growth-inducing factor. Moreover, these devices offer a solution for self-administration, catering to the growing emphasis on home-based healthcare and patient empowerment. Besides this, the rising awareness among individuals towards anaphylaxis, migraines, diabetes, and autoimmune disorders further fuels the adoption of autoinjectors. Furthermore, technological innovations, such as smart autoinjectors with connectivity features, exemplify Japan's commitment to cutting-edge healthcare solutions. Collaborations between pharmaceutical companies and device manufacturers result in enhanced product designs and usability. In line with this, sustainability is emerging as a notable trend, with a focus on eco-friendly materials and production processes, which is also catalyzing the market growth across the country. As Japan continues to navigate its evolving healthcare landscape, it will reflect a harmonious blend of numerous advancements and culturally specific healthcare needs, contributing to the nation's commitment to accessible and efficient healthcare solutions. This, in turn, is expected to fuel the market growth over the forecasted period.

Japan Autoinjector Market Segmentation:

Type Insights:

  • Disposable Autoinjectors
  • Reusable Autoinjectors

Application Insights:

  • Rheumatoid Arthritis
  • Anaphylaxis
  • Multiple Sclerosis
  • Others

End User Insights:

  • Home Care Settings
  • Hospitals and Clinics

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan autoinjector market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan autoinjector market?
  • What is the breakup of the Japan autoinjector market on the basis of type?
  • What is the breakup of the Japan autoinjector market on the basis of application?
  • What is the breakup of the Japan autoinjector market on the basis of end user?
  • What are the various stages in the value chain of the Japan autoinjector market?
  • What are the key driving factors and challenges in the Japan autoinjector?
  • What is the structure of the Japan autoinjector market and who are the key players?
  • What is the degree of competition in the Japan autoinjector market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Autoinjector Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Autoinjector Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Autoinjector Market - Breakup by Type

  • 6.1 Disposable Autoinjectors
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Reusable Autoinjectors
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)

7 Japan Autoinjector Market - Breakup by Application

  • 7.1 Rheumatoid Arthritis
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Anaphylaxis
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Multiple Sclerosis
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Others
    • 7.4.1 Historical and Current Market Trends (2019-2024)
    • 7.4.2 Market Forecast (2025-2033)

8 Japan Autoinjector Market - Breakup by End User

  • 8.1 Home Care Settings
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Hospitals and Clinics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)

9 Japan Autoinjector Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Autoinjector Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix